Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11959141 Multigene analysis of tumor samples

Patent 11959141 was granted and assigned to Foundation Medicine on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Foundation Medicine

Date Filed

December 4, 2015

Date of Patent

April 16, 2024

Patent Applicant

Foundation Medicine

Patent Application Number

15529237

Patent Citations

‌

US Patent 9834822 Systems and methods to detect rare mutations and copy number variation

‌

US Patent 9840743 Systems and methods to detect rare mutations and copy number variation

‌

US Patent 9850523 Methods for multi-resolution analysis of cell-free nucleic acids

‌

US Patent 9902992 Systems and methods to detect rare mutations and copy number variation

‌

US Patent 9920366 Methods and systems for detecting genetic variants

‌

US Patent 10041127 Systems and methods to detect rare mutations and copy number variation

‌

US Patent 11118213 Optimization of multigene analysis of tumor samples

‌

US Patent 11421265 Optimization of multigene analysis of tumor samples

‌

US Patent 11136619 Optimization of multigene analysis of tumor samples

‌

US Patent 7244567 Double ended sequencing

•••

Patent Inventor Names

Geoffrey Alan Otto

Michelle Nahas

Doron Lipson

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11959141

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11959141 Multigene analysis of tumor samples

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.